Pluristem Gets $3.3M Grant From Government

May 9, 2016 | Pluristem Therapeutics, an Israeli company developing placenta-based therapy products, announced that it was awarded a NIS 12.7 million (approx. $3.3 million) grant from the Israel Innovation Authority (previously the Office of the Chief Scientist ‘OCS’) of the Israeli Ministry of Economy & Industry. The grant will support Clinical trials and R&D activities for calendar year 2016. Pluristem was founded in 2001 by Shai Meretzki.